Edgewell Personal Care Company Chief Accounting Officer John M. Dunham filed a Form 4 on November 10, 2026, disclosing transactions dated November 9, 2026, involving the vesting and partial tax withholding of restricted stock equivalents in NYSE:EPC common stock.
Jessica Spence, President, Americas at Edgewell Personal Care Company, filed a Form 4 on November 12, 2026, reporting the vesting and conversion of restricted stock equivalents and a related tax-withholding share disposition on November 9, 2026.
Director Michael A. Beindorff filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 10,000 shares of Lifevantage Corp common stock on NASDAQ.
Edgewell Personal Care Co Chief Executive Officer Rod R. Little filed a Form 4 on November 12, 2026, reporting transactions dated November 9, 2026, related to the vesting and conversion of restricted stock equivalents originally granted November 8, 2024.
Edgewell Personal Care Co Chief Administrative and Legal Officer LaTanya Langley filed a Form 4 on November 10, 2026, reporting transactions in Edgewell common stock dated November 9, 2026, related to the vesting of restricted stock equivalents.
Eric W. Taylor, EVP and President of TFA at Tompkins Financial Corporation, filed a Form 4 on November 11, 2026, disclosing the acquisition of 630 shares of restricted common stock on November 9, 2026.
Rockwell Automation, Inc. filed an 8-K on November 12, 2026, announcing the introduction of its LogixEdge controller, a PC-based industrial control platform combining Logix control, edge computing, and containerized applications on a single platform.
Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri filed an amended beneficial ownership statement with the SEC on November 12, 2026, disclosing a combined 69,965-share position in Aptevo Therapeutics Inc. common stock, representing 3.72% of the class as of September 30, 2026.
A Schedule 13G filed on November 12, 2026, by MJL Manager LLC, Michael Liu, and Capuchin Capital Fund LP discloses a combined beneficial ownership of 159,378 shares of GRI Bio, Inc. common stock, representing 7.3% of the class, as of a triggering event dated …
Ayrton Capital LLC, Alto Opportunity Master Fund SPC - Segregated Master Portfolio B, and Waqas Khatri filed a Schedule 13G with the SEC on November 12, 2026, reporting beneficial ownership of common stock in Glucotrack, Inc. as of September 30, 2026.